India's High Court Delays Pfizer Sutent Decision Until Cipla Patent Ruling
This article was originally published in PharmAsia News
Executive Summary
India's highest court has put off until early January a hearing on Pfizer's suit to block a Cipla challenge of its patent on Sutent (sunitinib) for treating gastrointestinal and other tumors.